The antiviral drugs market is anticipated to flourish at an average CAGR of 3.9% between 2023 and 2033. The market is expected to hold a market share of USD 89.68 billion by 2033, while the market is likely to reach a value of USD 61.42 billion in 2023.
| Attributes | Details |
|---|---|
| Antiviral Drugs Market CAGR (2023 to 2033) | 3.9% |
| Antiviral Drugs Market Size (2023) | USD 61.42 billion |
| Antiviral Drugs Market Size (2033) | USD 89.68 billion |
Antiviral drugs are medicines that are used especially for treating viral infections. Most antiviral drugs are used for particular viral infections, similar to antibiotics, while a broad-spectrum antiviral drug is effective against a varied range of viruses. Antiviral drugs do not kill their target pathogen. Instead, they inhibit the development of those viruses.
The global antiviral drugs market is projected to register a moderate growth rate in the pharmaceutical market and is anticipated to increase due to a rise in awareness level, an increase in the diseased population, and the introduction of new drugs with improved efficacy.
Some key patents are reaching their expiry during the forecast periods, such as Combivir, Sustiva, Tenofovir, Tamiflu, Relenza, and Telbivudine. The patent expiries of these blockbuster drugs are expected to trigger generic competition in the antiviral therapeutics market, making the market more competitive.
The late-stage pipeline drugs are expected to enter the market, positively impacting the market. Most antivirals are considered comparatively harmless to the host and therefore are used to treat infections. They are different from viricides, which are not used for medication but can destroy or deactivate virus particles outside or inside the body. Antiviral drugs are used in the treatment of patients suffering from herpes viruses, HIV, influenza A and B viruses, and hepatitis B and C viruses.
The global demand for antiviral drugs is projected to increase at a CAGR of 3.9% during the forecast period between 2023 and 2033, reaching a total of USD 89.68 billion in 2033, according to a report from Future Market Insights (FMI). From 2018 to 2022, sales witnessed significant growth, registering a CAGR of 3.8%.
During the historical outlook, the biggest driver of the overall antiviral drugs market was Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) therapeutic sales, which accounted for more than half the share of the market in 2021. According to WHO, in 2021, several patients living with HIV are 38.4 million, and 650k people acquired the disease in the same year.
Nearly four out of five people were freshly put on treatment in sub-Saharan Africa. In 21 African countries with a high burden of HIV, two out of three people in need are receiving treatment, and two out of three positive pregnant women are receiving antiretroviral drugs to prevent HIV transmission to their infants.
The introduction of solid R&D activities, newer and advanced treatments, and formulations, such as vaccines and combination therapy, are projected to fuel the market growth of antiviral drugs over the forecast period.
The increasing commonness of viral infections such as HIV, Herpes, Influenza, and others is expected to upsurge the demand for antiviral medicines throughout the forecast period. For instance, according to UNAIDS, in 2020, more than 37 billion individuals were living with HIV across the globe.
Out of these, around 1.5 billion new people acquired HIV infection in 2020. Overall, the COVID-19 pandemic has pointedly accelerated the market growth in 2021, whereas a negative impact of the pandemic has been detected for other applications of antiviral drugs.
Owing to solid R&D activities, newer and advanced treatments, and formulations, such as vaccines, combination therapy, and others, are being introduced in the market, and the demand is anticipated to upsurge. Hence, strong R&D is one of the crucial factors in the antiviral drugs market growth.
Several factors hampering the market expansion of Antiviral Drugs include the high risk of failure, the high cost of R&D and therapy, and government austerity. However, the swelling usage of natural products and the high cost of developing drugs are the market's key challenges.
| Countries | Revenue Share % (2022) |
|---|---|
| United States | 7.1% |
| Germany | 5.8% |
| Japan | 6.4% |
| North America | 38.7% |
| Europe | 24.9% |
| Countries | CAGR % (2023 to 2033) |
|---|---|
| China | 4.7% |
| India | 3.8% |
| United Kingdom | 2.7% |
| Australia | 3.4% |
In terms of market contribution, North America acquired the leading share in revenue collection across the globe, accounting for a 38.7% share in 2022. As per the recent analysis by Future Market Insights, the region is anticipated to maintain its dominance during the assessment period 2022 to 2032. The United States and Canada are estimated to be the leading shareholders in regional revenue generation.
The market decline can be attributed to the loss of market exclusivity of patented drugs, mounting vaccination rates against viral infections, and government initiatives to minimize the prevalence of viral infections.
For instance, the United States government is responsible for several measures, including funding and grants in infectious diseases programs and encouraging the R&D activities of innovative therapies to manage viral infections.
Based on the geographies, European is the second-leading region, acquiring a 24.9% share in the antiviral drugs market. During the forecast period, the region is estimated to witness moderate growth, backed by soaring investments in the development of new drugs and therapies. This market growth is also attributed to the easy approval and promising healthcare policies by several governments.
In April 2022, European Medicines Agency, the European Union's drug regulator, signed off on emergency usage of Merck's Covid antiviral pill for adults who get tested positive as it prepares to decide on full approval by the year's end.
In July 2021, GSK and Vir announced a Joint Procurement Agreement (JPA) with the European Commission to supply up to 220,000 doses of sotrovimab. Following the grant of the marketing authorization in the EU, Member States participating in the JPA can now order sotrovimab to support their pandemic responses. These initiatives are likely to fuel the market growth of Antiviral Drugs in the coming years.
In the Asia Pacific, the market for antiviral drugs is anticipated to witness the fastest growth rate throughout the forecast period. The market's exponential growth can be attributed to the rising prevalence and treatment rate of viral infections, emerging healthcare infrastructure in the region, and growing awareness among people regarding infectious diseases.
Besides, the strong presence of generic pharmaceutical manufacturing companies in India, China, and other South Asian countries and the rising geriatric population in the region are some principal driving factors of the segment.
The introduction of new and innovative strategies in emerging economies is also likely to boost the demand for Antiviral Drugs over the coming decade.
| Category | By Application Type |
|---|---|
| Leading Segment | HIV |
| Market Share (2022) | 44.0% |
| Category | By End Use |
|---|---|
| Leading Segment | Hospitals |
| Market Share (2022) | 47.80% |
The global antiviral drugs market is segmented based on product type and end user. The HIV segment captured the majority share in terms of market revenue generation and held the leading revenue share of 44.0% in 2022.
The segment is projected to observe the fastest growth rate over the forecast period. The rising prevalence of HIV infection associated with a high treatment rate, availability of branded drugs, and government initiatives to upsurge the treatment rate is projected to stimulate the market at a higher growth rate.
For instance, in 2019, the United States government introduced the Ending the HIV Epidemic (EHE) plan to end the HIV epidemic in the country by 2032. The initiative seeks to decrease HIV infections and enhance the diagnosis and treatment rate in the United States. Furthermore, the existence of strong pipeline drugs for HIV infection may also fuel market growth throughout the conjecture period.
The hepatitis segment held the second-leading revenue share in 2021. Escalating vaccination against hepatitis A and B is affecting the growth adversely. Besides, the COVID-19 pandemic has significantly augmented the growth of the other segment in 2020.
Recent Developments:
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033
Table 2: Global Market Value (US$ Million) Forecast by Product type, 2018 to 2033
Table 3: Global Market Value (US$ Million) Forecast by End-user, 2018 to 2033
Table 4: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 5: North America Market Value (US$ Million) Forecast by Product type, 2018 to 2033
Table 6: North America Market Value (US$ Million) Forecast by End-user, 2018 to 2033
Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 8: Latin America Market Value (US$ Million) Forecast by Product type, 2018 to 2033
Table 9: Latin America Market Value (US$ Million) Forecast by End-user, 2018 to 2033
Table 10: Western Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 11: Western Europe Market Value (US$ Million) Forecast by Product type, 2018 to 2033
Table 12: Western Europe Market Value (US$ Million) Forecast by End-user, 2018 to 2033
Table 13: Eastern Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 14: Eastern Europe Market Value (US$ Million) Forecast by Product type, 2018 to 2033
Table 15: Eastern Europe Market Value (US$ Million) Forecast by End-user, 2018 to 2033
Table 16: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 17: South Asia and Pacific Market Value (US$ Million) Forecast by Product type, 2018 to 2033
Table 18: South Asia and Pacific Market Value (US$ Million) Forecast by End-user, 2018 to 2033
Table 19: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 20: East Asia Market Value (US$ Million) Forecast by Product type, 2018 to 2033
Table 21: East Asia Market Value (US$ Million) Forecast by End-user, 2018 to 2033
Table 22: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 23: Middle East and Africa Market Value (US$ Million) Forecast by Product type, 2018 to 2033
Table 24: Middle East and Africa Market Value (US$ Million) Forecast by End-user, 2018 to 2033
Figure 1: Global Market Value (US$ Million) by Product type, 2023 to 2033
Figure 2: Global Market Value (US$ Million) by End-user, 2023 to 2033
Figure 3: Global Market Value (US$ Million) by Region, 2023 to 2033
Figure 4: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033
Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 7: Global Market Value (US$ Million) Analysis by Product type, 2018 to 2033
Figure 8: Global Market Value Share (%) and BPS Analysis by Product type, 2023 to 2033
Figure 9: Global Market Y-o-Y Growth (%) Projections by Product type, 2023 to 2033
Figure 10: Global Market Value (US$ Million) Analysis by End-user, 2018 to 2033
Figure 11: Global Market Value Share (%) and BPS Analysis by End-user, 2023 to 2033
Figure 12: Global Market Y-o-Y Growth (%) Projections by End-user, 2023 to 2033
Figure 13: Global Market Attractiveness by Product type, 2023 to 2033
Figure 14: Global Market Attractiveness by End-user, 2023 to 2033
Figure 15: Global Market Attractiveness by Region, 2023 to 2033
Figure 16: North America Market Value (US$ Million) by Product type, 2023 to 2033
Figure 17: North America Market Value (US$ Million) by End-user, 2023 to 2033
Figure 18: North America Market Value (US$ Million) by Country, 2023 to 2033
Figure 19: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 22: North America Market Value (US$ Million) Analysis by Product type, 2018 to 2033
Figure 23: North America Market Value Share (%) and BPS Analysis by Product type, 2023 to 2033
Figure 24: North America Market Y-o-Y Growth (%) Projections by Product type, 2023 to 2033
Figure 25: North America Market Value (US$ Million) Analysis by End-user, 2018 to 2033
Figure 26: North America Market Value Share (%) and BPS Analysis by End-user, 2023 to 2033
Figure 27: North America Market Y-o-Y Growth (%) Projections by End-user, 2023 to 2033
Figure 28: North America Market Attractiveness by Product type, 2023 to 2033
Figure 29: North America Market Attractiveness by End-user, 2023 to 2033
Figure 30: North America Market Attractiveness by Country, 2023 to 2033
Figure 31: Latin America Market Value (US$ Million) by Product type, 2023 to 2033
Figure 32: Latin America Market Value (US$ Million) by End-user, 2023 to 2033
Figure 33: Latin America Market Value (US$ Million) by Country, 2023 to 2033
Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 37: Latin America Market Value (US$ Million) Analysis by Product type, 2018 to 2033
Figure 38: Latin America Market Value Share (%) and BPS Analysis by Product type, 2023 to 2033
Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Product type, 2023 to 2033
Figure 40: Latin America Market Value (US$ Million) Analysis by End-user, 2018 to 2033
Figure 41: Latin America Market Value Share (%) and BPS Analysis by End-user, 2023 to 2033
Figure 42: Latin America Market Y-o-Y Growth (%) Projections by End-user, 2023 to 2033
Figure 43: Latin America Market Attractiveness by Product type, 2023 to 2033
Figure 44: Latin America Market Attractiveness by End-user, 2023 to 2033
Figure 45: Latin America Market Attractiveness by Country, 2023 to 2033
Figure 46: Western Europe Market Value (US$ Million) by Product type, 2023 to 2033
Figure 47: Western Europe Market Value (US$ Million) by End-user, 2023 to 2033
Figure 48: Western Europe Market Value (US$ Million) by Country, 2023 to 2033
Figure 49: Western Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 50: Western Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 51: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 52: Western Europe Market Value (US$ Million) Analysis by Product type, 2018 to 2033
Figure 53: Western Europe Market Value Share (%) and BPS Analysis by Product type, 2023 to 2033
Figure 54: Western Europe Market Y-o-Y Growth (%) Projections by Product type, 2023 to 2033
Figure 55: Western Europe Market Value (US$ Million) Analysis by End-user, 2018 to 2033
Figure 56: Western Europe Market Value Share (%) and BPS Analysis by End-user, 2023 to 2033
Figure 57: Western Europe Market Y-o-Y Growth (%) Projections by End-user, 2023 to 2033
Figure 58: Western Europe Market Attractiveness by Product type, 2023 to 2033
Figure 59: Western Europe Market Attractiveness by End-user, 2023 to 2033
Figure 60: Western Europe Market Attractiveness by Country, 2023 to 2033
Figure 61: Eastern Europe Market Value (US$ Million) by Product type, 2023 to 2033
Figure 62: Eastern Europe Market Value (US$ Million) by End-user, 2023 to 2033
Figure 63: Eastern Europe Market Value (US$ Million) by Country, 2023 to 2033
Figure 64: Eastern Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 65: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 66: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 67: Eastern Europe Market Value (US$ Million) Analysis by Product type, 2018 to 2033
Figure 68: Eastern Europe Market Value Share (%) and BPS Analysis by Product type, 2023 to 2033
Figure 69: Eastern Europe Market Y-o-Y Growth (%) Projections by Product type, 2023 to 2033
Figure 70: Eastern Europe Market Value (US$ Million) Analysis by End-user, 2018 to 2033
Figure 71: Eastern Europe Market Value Share (%) and BPS Analysis by End-user, 2023 to 2033
Figure 72: Eastern Europe Market Y-o-Y Growth (%) Projections by End-user, 2023 to 2033
Figure 73: Eastern Europe Market Attractiveness by Product type, 2023 to 2033
Figure 74: Eastern Europe Market Attractiveness by End-user, 2023 to 2033
Figure 75: Eastern Europe Market Attractiveness by Country, 2023 to 2033
Figure 76: South Asia and Pacific Market Value (US$ Million) by Product type, 2023 to 2033
Figure 77: South Asia and Pacific Market Value (US$ Million) by End-user, 2023 to 2033
Figure 78: South Asia and Pacific Market Value (US$ Million) by Country, 2023 to 2033
Figure 79: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 80: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 81: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 82: South Asia and Pacific Market Value (US$ Million) Analysis by Product type, 2018 to 2033
Figure 83: South Asia and Pacific Market Value Share (%) and BPS Analysis by Product type, 2023 to 2033
Figure 84: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Product type, 2023 to 2033
Figure 85: South Asia and Pacific Market Value (US$ Million) Analysis by End-user, 2018 to 2033
Figure 86: South Asia and Pacific Market Value Share (%) and BPS Analysis by End-user, 2023 to 2033
Figure 87: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End-user, 2023 to 2033
Figure 88: South Asia and Pacific Market Attractiveness by Product type, 2023 to 2033
Figure 89: South Asia and Pacific Market Attractiveness by End-user, 2023 to 2033
Figure 90: South Asia and Pacific Market Attractiveness by Country, 2023 to 2033
Figure 91: East Asia Market Value (US$ Million) by Product type, 2023 to 2033
Figure 92: East Asia Market Value (US$ Million) by End-user, 2023 to 2033
Figure 93: East Asia Market Value (US$ Million) by Country, 2023 to 2033
Figure 94: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 95: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 96: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 97: East Asia Market Value (US$ Million) Analysis by Product type, 2018 to 2033
Figure 98: East Asia Market Value Share (%) and BPS Analysis by Product type, 2023 to 2033
Figure 99: East Asia Market Y-o-Y Growth (%) Projections by Product type, 2023 to 2033
Figure 100: East Asia Market Value (US$ Million) Analysis by End-user, 2018 to 2033
Figure 101: East Asia Market Value Share (%) and BPS Analysis by End-user, 2023 to 2033
Figure 102: East Asia Market Y-o-Y Growth (%) Projections by End-user, 2023 to 2033
Figure 103: East Asia Market Attractiveness by Product type, 2023 to 2033
Figure 104: East Asia Market Attractiveness by End-user, 2023 to 2033
Figure 105: East Asia Market Attractiveness by Country, 2023 to 2033
Figure 106: Middle East and Africa Market Value (US$ Million) by Product type, 2023 to 2033
Figure 107: Middle East and Africa Market Value (US$ Million) by End-user, 2023 to 2033
Figure 108: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033
Figure 109: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 110: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 111: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 112: Middle East and Africa Market Value (US$ Million) Analysis by Product type, 2018 to 2033
Figure 113: Middle East and Africa Market Value Share (%) and BPS Analysis by Product type, 2023 to 2033
Figure 114: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product type, 2023 to 2033
Figure 115: Middle East and Africa Market Value (US$ Million) Analysis by End-user, 2018 to 2033
Figure 116: Middle East and Africa Market Value Share (%) and BPS Analysis by End-user, 2023 to 2033
Figure 117: Middle East and Africa Market Y-o-Y Growth (%) Projections by End-user, 2023 to 2033
Figure 118: Middle East and Africa Market Attractiveness by Product type, 2023 to 2033
Figure 119: Middle East and Africa Market Attractiveness by End-user, 2023 to 2033
Figure 120: Middle East and Africa Market Attractiveness by Country, 2023 to 2033
The market is valued at USD 61.42 billion in 2023.
AstraZeneca, Cipla, Bayer AG are the key market players.
The growth potential of the market is 3.9% through 2033.
The market is estimated to reach USD 89.68 billion by 2033.
The market registered a CAGR of 3.8% from 2018 to 2022.
Explore Similar Insights
Antiviral Drugs Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
